Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GILD Gilead Sciences Inc

87,80

0,05 (0,06%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:19:11

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Gilead Sciences Charts.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Gilead Sciences Charts.

News Gilead Sciences Inc

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 15 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
Freitag 15 November 2024 (5 Tage vor) • Business Wire

Gilead Prices $3.5 Billion of Senior Unsecured Notes
Donnerstag 14 November 2024 (7 Tage vor) • Business Wire

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mittwoch 13 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 13 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
Mittwoch 13 November 2024 (1 Woche vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
Dienstag 12 November 2024 (1 Woche vor) • Business Wire

Gilead Sciences to Present at Upcoming Investor Engagements
Freitag 8 November 2024 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
Donnerstag 7 November 2024 (2 Wochen vor) • Business Wire

Weitere Gilead Sciences Inc News-Artikel

Deutsche Telekom

Deutsche Telekom (QX)

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen